ABVC Biopharma Stock Forward View - Price Action Indicator
| ABVC Stock | USD 1.90 0.12 5.94% |
ABVC Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast ABVC Biopharma stock prices and determine the direction of ABVC Biopharma's future trends based on various well-known forecasting models. We suggest always using this module together with an analysis of ABVC Biopharma's historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time, the RSI of ABVC Biopharma's share price is approaching 37. This suggests that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling ABVC Biopharma, making its price go up or down. Momentum 37
Sell Extended
Oversold | Overbought |
Wall Street Target Price 2.02 | Quarterly Revenue Growth 1.045 |
Using ABVC Biopharma hype-based prediction, you can estimate the value of ABVC Biopharma from the perspective of ABVC Biopharma response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards ABVC Biopharma using ABVC Biopharma's stock options and short interest. It helps to benchmark the overall future attitude of investors towards ABVC using crowd psychology based on the activity and movement of ABVC Biopharma's stock price.
ABVC Biopharma Implied Volatility | 0.0 |
ABVC Biopharma's implied volatility exposes the market's sentiment of ABVC Biopharma stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if ABVC Biopharma's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that ABVC Biopharma stock will not fluctuate a lot when ABVC Biopharma's options are near their expiration.
ABVC Biopharma after-hype prediction price | USD 1.87 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of ABVC Biopharma to cross-verify your projections. Open Interest Against 2026-03-20 ABVC Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast ABVC Biopharma's spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in ABVC Biopharma's options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for ABVC Biopharma stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current ABVC Biopharma's open interest, investors have to compare it to ABVC Biopharma's spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of ABVC Biopharma is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in ABVC. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
ABVC Biopharma Additional Predictive Modules
Most predictive techniques to examine ABVC price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for ABVC using various technical indicators. When you analyze ABVC charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Price Action Indicator | Price Action Indicator | Trend |
| (0.16) | (0.16) |
| Check ABVC Biopharma Volatility | Backtest ABVC Biopharma | Information Ratio |
ABVC Biopharma Trading Date Momentum
| On February 02 2026 ABVC Biopharma was traded for 1.90 at the closing time. The top price for the day was 2.10 and the lowest listed price was 1.90 . There was no trading activity during the period 0.0. Lack of trading volume on February 2, 2026 did not affect price variability. The overall trading delta against the current closing price is 6.32% . |
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
| Compare ABVC Biopharma to competition |
Other Forecasting Options for ABVC Biopharma
For every potential investor in ABVC, whether a beginner or expert, ABVC Biopharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. ABVC Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in ABVC. Basic forecasting techniques help filter out the noise by identifying ABVC Biopharma's price trends.ABVC Biopharma Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ABVC Biopharma stock to make a market-neutral strategy. Peer analysis of ABVC Biopharma could also be used in its relative valuation, which is a method of valuing ABVC Biopharma by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
ABVC Biopharma Market Strength Events
Market strength indicators help investors to evaluate how ABVC Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading ABVC Biopharma shares will generate the highest return on investment. By undertsting and applying ABVC Biopharma stock market strength indicators, traders can identify ABVC Biopharma entry and exit signals to maximize returns.
ABVC Biopharma Risk Indicators
The analysis of ABVC Biopharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in ABVC Biopharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting abvc stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.05 | |||
| Standard Deviation | 3.86 | |||
| Variance | 14.92 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for ABVC Biopharma
The number of cover stories for ABVC Biopharma depends on current market conditions and ABVC Biopharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that ABVC Biopharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about ABVC Biopharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
ABVC Biopharma Short Properties
ABVC Biopharma's future price predictability will typically decrease when ABVC Biopharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of ABVC Biopharma often depends not only on the future outlook of the potential ABVC Biopharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. ABVC Biopharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 11.7 M | |
| Cash And Short Term Investments | 928.6 K |
Check out Historical Fundamental Analysis of ABVC Biopharma to cross-verify your projections. For information on how to trade ABVC Stock refer to our How to Trade ABVC Stock guide.You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Will Biotechnology sector continue expanding? Could ABVC diversify its offerings? Factors like these will boost the valuation of ABVC Biopharma. If investors know ABVC will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every ABVC Biopharma data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.28) | Revenue Per Share | Quarterly Revenue Growth 1.045 | Return On Assets | Return On Equity |
Understanding ABVC Biopharma requires distinguishing between market price and book value, where the latter reflects ABVC's accounting equity. The concept of intrinsic value—what ABVC Biopharma's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push ABVC Biopharma's price substantially above or below its fundamental value.
Understanding that ABVC Biopharma's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether ABVC Biopharma represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, ABVC Biopharma's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.